terazosin hydrochloride

Generic: terazosin hydrochloride

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin hydrochloride
Generic Name terazosin hydrochloride
Labeler aphena pharma solutions - tennessee, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 2 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-698
Product ID 71610-698_c97f447e-0233-4a6c-9bed-7dec551aaa95
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074823
Listing Expiration 2026-12-31
Marketing Start 2020-06-30

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610698
Hyphenated Format 71610-698

Supplemental Identifiers

RxCUI
313217
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin hydrochloride (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA074823 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (71610-698-30)
  • 60 CAPSULE in 1 BOTTLE (71610-698-53)
  • 90 CAPSULE in 1 BOTTLE (71610-698-60)
  • 120 CAPSULE in 1 BOTTLE (71610-698-70)
  • 180 CAPSULE in 1 BOTTLE (71610-698-80)
  • 270 CAPSULE in 1 BOTTLE (71610-698-92)
  • 360 CAPSULE in 1 BOTTLE (71610-698-94)
source: ndc

Packages (7)

Ingredients (1)

terazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c97f447e-0233-4a6c-9bed-7dec551aaa95", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["9199083d-403f-4c9e-90e1-713ed0a07903"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71610-698-30)", "package_ndc": "71610-698-30", "marketing_start_date": "20230404"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71610-698-53)", "package_ndc": "71610-698-53", "marketing_start_date": "20230404"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71610-698-60)", "package_ndc": "71610-698-60", "marketing_start_date": "20230404"}, {"sample": false, "description": "120 CAPSULE in 1 BOTTLE (71610-698-70)", "package_ndc": "71610-698-70", "marketing_start_date": "20230404"}, {"sample": false, "description": "180 CAPSULE in 1 BOTTLE (71610-698-80)", "package_ndc": "71610-698-80", "marketing_start_date": "20230404"}, {"sample": false, "description": "270 CAPSULE in 1 BOTTLE (71610-698-92)", "package_ndc": "71610-698-92", "marketing_start_date": "20230404"}, {"sample": false, "description": "360 CAPSULE in 1 BOTTLE (71610-698-94)", "package_ndc": "71610-698-94", "marketing_start_date": "20230404"}], "brand_name": "Terazosin Hydrochloride", "product_id": "71610-698_c97f447e-0233-4a6c-9bed-7dec551aaa95", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-698", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin Hydrochloride", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA074823", "marketing_category": "ANDA", "marketing_start_date": "20200630", "listing_expiration_date": "20261231"}